Vaxxinity, Inc. (VAXX)

OTCMKTS: VAXX · Delayed Price · USD

0.275

-0.025 (-8.37%)

Jul 2, 2024, 3:46 PM EDT - Market closed

Vaxxinity Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-56.93	-75.21	-138.02	-35.38	-14.22
Depreciation & Amortization	2.23	1.68	1.1	0.72	0.11
Share-Based Compensation	7.51	8.71	30.41	1.01	1.23
Other Operating Activities	-10.05	8.88	25.51	-0.26	0.62
Operating Cash Flow	-57.24	-55.93	-80.99	-33.91	-12.27
Capital Expenditures	-0.8	-1.87	-1.32	-1.48	0
Acquisitions	-0.03	52.53	0	0	0
Change in Investments	-157.53	-162.53	-	-	-
Other Investing Activities	187.21	57.47	-	-	-
Investing Cash Flow	28.84	-54.39	-1.32	-1.48	0
Common Stock Issued	0.45	0.26	71.08	59.81	0.02
Share Repurchases	0	0	0	-0.04	0
Other Financing Activities	-1.59	-0.43	125.09	6.25	11.12
Financing Cash Flow	-1.14	-0.17	196.17	66.11	11.14
Net Cash Flow	-29.53	-110.49	113.86	30.72	-1.13
Free Cash Flow	-58.04	-57.79	-82.31	-35.39	-12.27
Free Cash Flow Margin	-	-	-124709.09%	-6353.14%	-
Free Cash Flow Per Share	-0.46	-0.46	-0.66	-0.28	-0.10

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.